Jamie Murphy

Jamie Murphy, CPA, and M.B.A. bring more than 10 years of financial experience in biotechnology and life sciences to his role at Sigilon. Before joining Sigilon, he served as the controller of Zafgen Inc. where he played an integral role in the completion of Zafgen’s reverse merger with Larimar Therapeutics. Following the completion of the merger, he served as a financial consultant at Larimar Therapeutics where he led the accounting group's transition to being a publicly traded company. He began his career at PricewaterhouseCoopers LLP where he was a manager in their Boston office’s health industry practice and provided accounting and auditing services to a range of public and private biotech and life science companies. He is a Certified Public Accountant, received his BS in business and history from Wake Forest University and also received his Masters of Accounting and Masters of Business Administration from Northeastern University.